Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: HIV AND HEPATITIS POLICY INSTITUTE, HIV AND HEPATITIS POLICY INSTITUTE
Client-Reported Lobbying Expenses
$170K
11 filings
Firm Income Reported for This Client
$120K
Not substituted for client expenses
Summary
HIV AND HEPATITIS POLICY INSTITUTE is an organization, based in DC. Its political footprint includes $170K in client-reported lobbying expenses, $120K in lobbying-firm income reported for this client. Lobbying activity focuses on Health Issues, Pharmacy, Insurance, Budget/Appropriations. Political activity spans from 2025 to 2026.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Lobbying Spend Trend
↑ 140% YoY
2026: $120K (available years)
Activity data: Senate LDA